Israel didn't slow down. Its health‑tech industry hit a financing gap — and that's the opportunity.
A one‑page case for why global capital and philanthropy should back Israeli health‑tech now, and why 8400 Health Network is the organization built to convert that capital into compounding impact.
The Opportunity — Israel as a Health‑Tech Investment Destination
Israel builds health‑tech companies at a density almost no other country matches. What it lacks isn't science, talent, or proof points — it's the growth‑stage capital to turn that edge into scaled, world‑leading companies.
Israeli health‑tech investment, 2021–2025
USD, private & VC investmentMilitary‑to‑market pipeline. Elite IDF tech units feed computer‑vision and data talent directly into health‑AI founding teams — a talent engine most ecosystems can't replicate.
A national data moat. A universal system covering 98% of the population across four HMOs holds ~25 years of longitudinal digitized records — rare, structured training data for clinical AI.
Research firepower. Israel ranks 5th in the world for scientific discoveries and 12th overall in the World Index of Healthcare Innovation — ahead of every economy its size.
Proof at flagship scale. Sheba Medical Center — a top‑10 global hospital — just launched a three‑year genomic‑AI program with NVIDIA and Mount Sinai, showing Israeli clinical infrastructure can anchor the world's most advanced AI‑health partnerships.
AI × Drug Discovery
~70% of these are backed by the Israel Innovation Authority, which directed 29% of its entire 2025 budget (≈NIS 560M) into health‑tech — riding the same AI wave lifting Rock Health's record $14.2B U.S. digital‑health year.
Mental Health / "TraumaTech"
$352M raised across 178 companies (80% early‑stage). 3 of the year's 5 largest health‑tech rounds were mental‑health deals — Israel is becoming a global proving ground for trauma‑informed care technology.
Biomed & Genomics
Biomed represents ~30% of active companies but over half the sector's 81,000 employees — the steadiest sub‑sector through every funding cycle, and the base for Israel's next generation of precision‑medicine platforms.
The gap isn't invention — it's scale. Average deal size fell below $10M in 2025 for the first time in five years, and the Tel Aviv Stock Exchange has recorded zero health‑tech IPOs for three straight years. Israel converts research into seed‑stage companies faster than almost anywhere on earth; it doesn't yet convert enough of them into scaled, IPO‑ready category leaders.
Corporate partners, strategic investors and philanthropic donors who bridge that growth‑stage gap aren't funding a shortfall — they're funding the highest‑leverage stage of a proven pipeline.
The Accelerator — How 8400 Turns This Opportunity Into Outcomes
8400 Health Network is the connective tissue across Israel's health‑tech ecosystem — the one organization that already sits inside the rooms where capital, government, hospitals and founders make decisions together.
Bringing investors, founders, corporates, scientists & physicians to one table
The flagship Fellowship, built with Harvard Business School, seats senior leaders from industry, government, healthcare providers and philanthropy in a single annual cohort. The Directors Program and Global Experts Network extend that table to global corporate and investor leadership year‑round.
Bringing government budget to the ecosystem
8400's network runs directly through 11 government ministries and the Israel Innovation Authority's health‑tech funding tracks. It is the connective tissue that keeps public capital aimed at real ecosystem gaps instead of scattering across disconnected initiatives.
Directing the ecosystem to the highest‑potential white space
8400 co‑authored the 2025 research that first identified and quantified the mental‑health / TraumaTech surge — the same +150% growth sector flagged on the opposite page — turning a real‑time signal into ecosystem‑wide focus and capital.
Training entrepreneurs to succeed
A dedicated Programs Incubator spans the full founder pipeline — from academic lab to investable company — through mentoring, a regulatory degree track, and named programs built for every stage and specialty.
Israel didn't run out of breakthroughs in 2025 — it ran into a financing gap between world‑class research and world‑scale companies. 8400 is built to close that exact gap. A philanthropic dollar here doesn't fund one startup; it funds the connective tissue that lets Israel's health‑tech engine compound.